Morphosys Ag (MOR) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
MorphoSys AG has issued a notification of major holdings, indicating a change in voting rights as per the German Securities Trading Act. Royalty Pharma PLC, previously holding 3.91% of voting rights, has now reported a total of 0.00% in both direct and indirect voting rights. This significant shift in shareholder voting power has been officially announced by MorphoSys AG to ensure Europe-wide distribution of this critical information.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.